Close Menu

Linguamatics

Now a subsidiary of IQvia, NLP vendor Linguamatics also is looking to help precision medicine providers and pharma researchers with phenotype-genotype matching.

CRO and analytics giant IQvia, the product of the IMS Health-Quintiles merger, quietly purchased UK-based bioinformatics company Linguamatics a month ago.

Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.

Version 5.0 of the software features tools for normalizing concepts such as gene mutations and additional query features for mining text documents.

CollabRx has launched CancerRx, a new oncology application that runs on Apple's operating system. The app provides oncologists and pathologists with treatment options that are based on their patients' tumors and also offers a daily newsfeed from MedPage Today.

RefSeq 65 is now available from the National Center for Biotechnology Information via FTP.

Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.

Linguamatics said this week that researchers at the University of Utah's Huntsman Cancer Institute are using Linguamatics I2E, the company's text mining software solution, to extract information from electronic health records that could help them better understand cancer and impr

Agilent Technologies has released a new version of its electronic laboratory notebook software.

The TranSMART Foundation has launched a new version of the open source knowledge management platform.

Pages

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.